Antonia Vila

714 total citations
22 papers, 543 citations indexed

About

Antonia Vila is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Antonia Vila has authored 22 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Virology and 6 papers in Emergency Medicine. Recurrent topics in Antonia Vila's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (6 papers). Antonia Vila is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (6 papers). Antonia Vila collaborates with scholars based in Spain, United Kingdom and United States. Antonia Vila's co-authors include Annet Heuvelink, Thijs Bosch, Xander W. Huijsdens, Albert J. de Neeling, J.T.M. Zwartkruis-Nahuis, E de Boer, Ben Wit, Daniel Podzamczer, Jordí Niubó and Juan Tiraboschi and has published in prestigious journals such as The Journal of Infectious Diseases, International Journal of Food Microbiology and AIDS.

In The Last Decade

Antonia Vila

20 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonia Vila Spain 10 370 223 106 94 83 22 543
Joe Huong United States 7 277 0.7× 93 0.4× 95 0.9× 17 0.2× 57 0.7× 8 559
Roberto L. Patron United States 11 336 0.9× 170 0.8× 94 0.9× 15 0.2× 32 0.4× 18 514
Kristi L. Strandberg United States 14 212 0.6× 179 0.8× 42 0.4× 29 0.3× 74 0.9× 16 632
C S Weikel United States 13 236 0.6× 112 0.5× 60 0.6× 11 0.1× 63 0.8× 20 545
Michael J. Aldape United States 13 446 1.2× 103 0.5× 160 1.5× 8 0.1× 21 0.3× 19 647
Ferhat Arslan Türkiye 12 132 0.4× 41 0.2× 25 0.2× 64 0.7× 55 0.7× 60 539
Alejandro Pironti United States 12 153 0.4× 181 0.8× 39 0.4× 5 0.1× 24 0.3× 37 569
Paul M. Luethy United States 11 158 0.4× 99 0.4× 65 0.6× 10 0.1× 61 0.7× 31 510
Samar M. Solyman Egypt 13 291 0.8× 286 1.3× 144 1.4× 54 0.6× 36 0.4× 31 485
Margarete Borg‐von Zepelin Germany 15 546 1.5× 132 0.6× 20 0.2× 20 0.2× 71 0.9× 20 780

Countries citing papers authored by Antonia Vila

Since Specialization
Citations

This map shows the geographic impact of Antonia Vila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonia Vila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonia Vila more than expected).

Fields of papers citing papers by Antonia Vila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonia Vila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonia Vila. The network helps show where Antonia Vila may publish in the future.

Co-authorship network of co-authors of Antonia Vila

This figure shows the co-authorship network connecting the top 25 collaborators of Antonia Vila. A scholar is included among the top collaborators of Antonia Vila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonia Vila. Antonia Vila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Saumoy, María, Carlos Alonso‐Villaverde, Montserrat Olmo, et al.. (2016). Randomized trial of a multidisciplinary lifestyle intervention in HIV-infected patients with moderate-high cardiovascular risk. Atherosclerosis. 246. 301–308. 18 indexed citations
3.
Imaz, Arkaitz, Javier Martínez‐Picado, Jordí Niubó, et al.. (2016). HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen. The Journal of Infectious Diseases. 214(10). 1512–1519. 24 indexed citations
4.
Imaz, Arkaitz, Jordí Niubó, Angela D. M. Kashuba, et al.. (2016). Elvitegravir concentrations in seminal plasma in HIV‐1‐infected men. HIV Medicine. 18(3). 225–230. 8 indexed citations
5.
Casas, Lidia, et al.. (2016). La práctica de esterilización en niñas y mujeres competentes y con discapacidad psíquica o intelectual en Chile. Dialnet (Universidad de la Rioja). 173–216. 1 indexed citations
6.
Imaz, Arkaitz, Mariana Camoez, Oriol Gasch, et al.. (2015). Prevalence of methicillin-resistant Staphylococcus aureus colonization in HIV-infected patients in Barcelona, Spain: a cross-sectional study. BMC Infectious Diseases. 15(1). 243–243. 18 indexed citations
7.
Moltó, José, Elena Ferrer, Adrián Curran, et al.. (2015). Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression. Journal of Antimicrobial Chemotherapy. 70(5). 1513–1516. 8 indexed citations
8.
Tiraboschi, Juan, Hernando Knobel, Arkaitz Imaz, et al.. (2015). Cerebrospinal Fluid and Plasma Lopinavir Concentrations and Viral Response in Virologically Suppressed Patients Switching to Lopinavir/Ritonavir Monotherapy Once Daily. Antiviral Therapy. 21(4). 359–363. 3 indexed citations
9.
Eynde, Eva Van den, Jordi Curto, Elena Ferrer, et al.. (2015). Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients. AIDS. 29(8). 977–979.
10.
Tiraboschi, Juan, Arkaitz Imaz, Elena Ferrer, et al.. (2014). CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily. Journal of the International AIDS Society. 17(4S3). 19587–19587. 2 indexed citations
11.
Moltó, José, Elena Ferrer, Adrián Curran, et al.. (2014). DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTI. Journal of the International AIDS Society. 17(4S3). 19821–19821. 4 indexed citations
12.
Tiraboschi, Juan, Jordí Niubó, Antonia Vila, Sílvia Pérez‐Pujol, & Daniel Podzamczer. (2012). Etravirine concentrations in CSF in HIV-infected patients. Journal of Antimicrobial Chemotherapy. 67(6). 1446–1448. 22 indexed citations
13.
Saumoy, María, et al.. (2011). Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study). HIV Medicine. 12(7). 438–441. 8 indexed citations
14.
Boer, E de, J.T.M. Zwartkruis-Nahuis, Ben Wit, et al.. (2008). Prevalence of methicillin-resistant Staphylococcus aureus in meat. International Journal of Food Microbiology. 134(1-2). 52–56. 332 indexed citations
15.
Vila, Antonia, et al.. (2005). Allergic contact dermatitis due to rosemary. Contact Dermatitis. 53(3). 179–180. 9 indexed citations
16.
Peramiquel, Laura, et al.. (2005). Occupational contact dermatitis from simvastatin. Contact Dermatitis. 52(5). 286–287. 14 indexed citations
17.
Dalmau, Josep, et al.. (2005). Meat protein allergic contact dermatitis: A case report. Contact Dermatitis. 52(5). 285–286. 6 indexed citations
18.
Vila, Antonia, L. Puig, María Teresa Fernández‐Figueras, et al.. (2005). Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients. British Journal of Dermatology. 153(2). 417–423. 32 indexed citations
19.
Vila, Antonia, et al.. (2004). Úlceras por presión: prevención y tratamiento. 18(4). 43–52.
20.
Vila, Antonia, María A. Barnadas, José Ballarín, et al.. (2004). Cutaneous ulcers with type I cryoglobulinemia treated with plasmapheresis.. PubMed. 14(3). 186–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joe Huong Breakdown of academic impact, for papers by Roberto L. Patron Breakdown of academic impact, for papers by Kristi L. Strandberg Breakdown of academic impact, for papers by C S Weikel Breakdown of academic impact, for papers by Michael J. Aldape Breakdown of academic impact, for papers by Ferhat Arslan Breakdown of academic impact, for papers by Alejandro Pironti Breakdown of academic impact, for papers by Paul M. Luethy Breakdown of academic impact, for papers by Samar M. Solyman Breakdown of academic impact, for papers by Margarete Borg‐von Zepelin
Rankless by CCL
2026